Inventor · disambiguated record
Frederik Jan Rita Rombouts
Also filed as: ROMBOUTS FREDERIK JAN RITA
15 granted patents·20 pending applications·15 citations·filing 2005–2025
87Inventor score
Files withJANSSEN PHARMACEUTICA NV25FREYNE EDDY JEAN EDGARD3AUGUSTINE THERAPEUTICS2ANDRES-GIL JOSE IGNACIO1JANSSEN PHARMACEUTICALS INC1
Top patents by PatentIndex Score
35 records- 0183US8394786B2Quinazoline derivativesFREYNE EDDY JEAN EDGARD·Filed 2009·Granted Mar 12, 2013·5 cites·8 claims
- 0282US8148388B22,4 (4,6) pyrimidine derivativesFREYNE EDDY JEAN EDGARD·Filed 2005·Granted Apr 3, 2012·6 cites·31 claims
- 0370US9828350B25,6-dihydro-2H-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (BACE)JANSSEN PHARMACEUTICA NV·Filed 2016·Granted Nov 28, 2017·1 cites·4 claims
- 0467US9181245B2Substituted pyrido[1,2-a]pyrazines and substituted pyrido[1,2-a][1,4]diazepines for the treatment of (inter alia) Alzheimer's diseaseJANSSEN PHARMACEUTICALS INC·Filed 2013·Granted Nov 10, 2015·1 cites·14 claims
- 0567US8946266B2Substituted triazole and imidazole derivatives as gamma secretase modulatorsWU TONGFEI·Filed 2010·Granted Feb 3, 2015·2 cites·14 claims
- 0663US12006302B2Tau PET imaging ligandsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jun 11, 2024·0 cites·2 claims
- 0758US9273013B2Quinazoline derivativesJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Mar 1, 2016·0 cites·1 claims
- 0858US2021283277A1Tau pet imaging ligandsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0957US2024190893A1Macrocyclic 1,3-bridged 6-chloro-7-pyrazol-4-yl-1 h-indole-2-carboxylate and 6-chloro-7-pyrimidin-5-yl-1h-indole-2-carboxylate derivatives as mcl-1 inhibitors for the treatment of cancerJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1056US2024083890A1Macrocyclic branched 3-fluoro-but-3-enamides as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1155US11168068B2Tau PET imaging ligandsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 9, 2021·0 cites·16 claims
- 1255US2023219906A1Macrocyclic-2-amino-3-fluoro-but-3-enamides as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1354US2025051319A1Compounds and use thereof as hdac6 inhibitorsAUGUSTINE THERAPEUTICS·Filed 2022·Application pending·0 cites
- 1453US2024239812A1Macrocyclic 2-allyltetrahydrofurans as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1553US2016207938A1Quinazoline derivativesJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 1653US2024124487A1Branched macrocyclic 4-(pyrazol-5-yl)-indole derivatives as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1752US12421222B2Substituted quinazolines as HDAC6 inhibitorsAUGUSTINE THERAPEUTICS·Filed 2025·Granted Sep 23, 2025·0 cites·29 claims
- 1852US2023265105A1Macrocyclic 7-pyrazol-5-yl-indole derivatives as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1951US2023234965A1N-linked macrocyclic 4-(pyrazol-5-yl)-indole derivatives as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2051US2024067660A1Macrocyclic spirocycle derivatives as mcl-1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 2151US2023029194A1Macrocylic sulfonyl derivatives mcl-1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 2251US2023234969A1N-linked macrocyclic 7-(pyrazol-5-yl)-indole derivatives as inhibiors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2351US2023021562A1Macrocylic indole derivatives mcl-1 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 2450US2023250109A1Macrocyclic ether containing indole derivatives as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2549US2023130109A1Macrocyclic indole derivatives as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2648US10562897B2Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Feb 18, 2020·0 cites·11 claims
- 2748US8394955B22,4 (4,6) pyrimidine derivativesFREYNE EDDY JEAN EDGARD·Filed 2011·Granted Mar 12, 2013·0 cites·4 claims
- 2847US2019038784A1Tau pet imaging ligandsJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 2945US10604523B21-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivativesANDRES GIL JOSE IGNACIO·Filed 2012·Granted Mar 31, 2020·0 cites·2 claims
- 3045US2022306653A1Macrocyclic inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 3144US10112943B2Substituted imidazoles as gamma secretase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Oct 30, 2018·0 cites·14 claims
- 3242US10246454B2Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 2, 2019·0 cites·11 claims
- 3341US2013109683A15,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)TRABANCO-SUAREZ ANDRES AVELINO·Filed 2011·Application pending·0 cites
- 3439US2018334447A12,3,4,5-tetrahydropyridin-6-amine derivativesJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 3537US8778919B2Cyclic anilino—pyridinotriazinesROMBOUTS FREDERIK JAN RITA·Filed 2006·Granted Jul 15, 2014·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Frederik Jan Rita Rombouts files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →